High post‐chemotherapy TIL and increased CD4+TIL are independent prognostic factors of surgically resected NSCLC following neoadjuvant chemotherapy

High post‐chemotherapy TIL and increased CD4+TIL are independent prognostic factors of surgically resected NSCLC following neoadjuvant chemotherapy

Abstract Neoadjuvant chemotherapy (NCT) has significantly improved the overall survival of patients with operable non‐small cell lung cancer (NSCLC). Chemotherapy can remodel the tumor immune microenvironment (TIME) and has an important influence on antitumor immunity. For patients who underwent sur...

Full description

Bibliographic Details
Main Authors: Wenxiao Jia, Hongbo Guo, Min Wang, Ji Li, Jinming Yu, Hui Zhu, Gang Wu
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:MedComm
Subjects:
CD4
CD8
immunotherapy
neoadjuvant chemotherapy
NSCLC
tumor‐infiltrating lymphocyte
Online Access:https://doi.org/10.1002/mco2.213

Similar Items

Similar Items